Company Directory > CRO > Avastus Preclinical Services
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Avastus Preclinical Services and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Avastus Preclinical Services is a contract research organization (CRO) based in Cambridge, Massachusetts, specializing in preclinical research support. The company provides a range of services including in vivo disease modeling, in vitro assay development, and vivarium management. They support pharmaceutical and biotechnology companies by offering flexible laboratory space, animal husbandry, and regulatory compliance services. Beyond core CRO activities, Avastus provides comprehensive vivarium operations and facility management, including IACUC representation, protocol design, and veterinary oversight. Their expertise spans various therapeutic areas such as oncology, metabolic diseases (obesity/diabetes), inflammatory diseases, and infectious diseases, helping clients navigate the preclinical stages of drug development.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Preclinical Research Services
SIZE & FINANCIALS
Employees:1-50
Founded:2013
Ownership:private
Status:operating
FUNDING
Total Raised:$0
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Antibody
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Revvity (Imaging platforms)
COMPETITION
Position:Niche Player
Competitors:TransCure bioServices, GenOway, Alpha Genesis
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Avastus Preclinical Services. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.